COMMUNIQUÉS West-GlobeNewswire

LIDDS: Liproca® Depot effects on prostate cancer to be presented at the Paris Symposium for Magnetic Resonance in Medicine

08/02/2018 - 08:30

The scientific results from intratumoral injections with Liproca® Depot as confirmed by Magnetic Resonance Imaging and Spectroscopy, have been accepted for presentation at the International Society for Magnetic [...]

Herantis Pharma completes patient enrolment in Phase 1 study of Lymfactin gene therapy for secondary lymphedema and has submitted Phase 2 application

08/02/2018 - 08:01

Herantis Pharma completes patient enrolment in Phase 1 study of Lymfactin gene therapy for secondary lymphedema and has submitted Phase 2 application Herantis Pharma Plc Company release 8 Feb 2018 at 9:00 am Herantis [...]

ERYTECH to Present at the 2018 BIO CEO & Investor Conference

08/02/2018 - 07:31

ERYTECH to Present at the 2018 BIO CEO & Investor Conference LYON, France - February 8, 2018 - ERYTECH Pharma (Euronext Paris: ERYP, Nasdaq: ERYP), a clinical-stage biopharmaceutical company developing innovative [...]

Novartis receives FDA approval for Cosentyx® label update to include moderate-to-severe scalp psoriasis

08/02/2018 - 07:16

US label updated to include Cosentyx ® (secukinumab) data in moderate-to-severe scalp psoriasis[1] - one of the difficult-to-treat types of psoriasis[2] Approximately half of all 125 million patients with psoriasis [...]

VIFOR PHARMA FERROPORTIN INHIBITOR ENTERS PHASE-I CLINICAL TRIAL

08/02/2018 - 06:59

vifor pharma announced today that vit-2763, the first-ever oral ferroportin inhibitor for preventing iron overload, will enter clinical development with a phase-i study at the beginning of March 2018. first results from [...]

Ligandal CEO Unveils Nanotech Delivery for Genetic Therapies: “What Good Would Amazon Be Without the Shipping?”

08/02/2018 - 02:08

SAN DIEGO, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Cures for sickle cell, hemophilia and a host of other genetic-based diseases are on the horizon because of nanotechnology that can now deliver CRISPR , mRNA, and other [...]

First Choice Healthcare Solutions Announces Strategic Partnership and Equity Investment with Steward Health Care

08/02/2018 - 01:46

Management to Host Shareholder Update Conference Call to Discuss Strategic Partnership in Further Detail on Thursday, February 8th at 11:00 a.m. ET MELBOURNE, Fla., Feb. 07, 2018 (GLOBE NEWSWIRE) -- First Choice [...]

MediciNova Announces Pricing of Underwritten Public Offering of Common Stock

08/02/2018 - 01:12

LA JOLLA, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]

Gemphire Announces Proposed Public Offering of Common Stock

07/02/2018 - 22:32

LIVONIA, Mich., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Gemphire Therapeutics Inc. (NASDAQ: GEMP ), a clinical-stage biopharmaceutical company focused on developing and commercializing therapies for cardiometabolic disorders [...]

Precision Optics Corporation Schedules Second Quarter Conference Call

07/02/2018 - 22:30

GARDNER, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Precision Optics Corporation, Inc. (OTCQB:PEYE) (the "Company") announced that it intends to release its financial results for the fiscal year 2018 second quarter ended [...]

Akari Therapeutics to Present at the Leerink Partners Global Healthcare Conference

07/02/2018 - 22:30

NEW YORK and LONDON, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Akari Therapeutics, Plc (NASDAQ: AKTX ) (“Akari” or “the Company”), a biopharmaceutical company focused on the development and commercialization of innovative [...]

Tonix Pharmaceuticals to Present at the 20th Annual BIO CEO & Investor Conference in New York City

07/02/2018 - 22:30

NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP ) (Tonix), a clinical-stage biopharmaceutical company focused on discovering and developing pharmaceutical products to treat [...]

Insmed to Present at the Leerink Partners 7th Annual Global Healthcare Conference

07/02/2018 - 22:30

BRIDGEWATER, N.J., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Insmed Incorporated (Nasdaq: INSM ), a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced that Will Lewis, [...]

Prothena to Participate in the Leerink Partners 7th Annual Global Healthcare Conference

07/02/2018 - 22:05

DUBLIN, Ireland, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (NASDAQ: PRTA ), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel therapies in [...]

ConforMIS Reports Fourth Quarter and the Year Ended 2017 Financial Results; Reiterates 2018 Financial Guidance

07/02/2018 - 22:05

BILLERICA, Mass., Feb. 07, 2018 (GLOBE NEWSWIRE) -- ConforMIS, Inc. (NASDAQ: CFMS ), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, manufacture and sell [...]

Intercept to Report 2017 Full Year Financial Results on February 14 and Present at Upcoming Conferences

07/02/2018 - 22:05

NEW YORK, Feb. 07, 2018 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT ), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non- [...]

GBT Announces Participation at the Leerink Partners 7th Annual Global Healthcare Conference

07/02/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT ) today announced that it will present at the Leerink Partners 7 th Annual Global Healthcare Conference [...]

Sunesis Pharmaceuticals Appoints Industry Veteran H. Ward Wolff to the Board of Directors

07/02/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., Feb. 07, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS ) today announced that H. Ward Wolff has been appointed to the Sunesis Board of Directors. Mr. Wolff brings over [...]

Sonoma Pharmaceuticals Reports Record Total Revenue of $4.8 million for Third Quarter FY 2018 with Year over Year Product Revenue Growth of 46%

07/02/2018 - 22:05

Product revenue up 12% compared to September 2017 quarter U.S. product revenue up 27% compared to the September 2017 quarter Cash on hand equals $8.6 million at quarter end Conference Call Begins at 4:30pm EST Today [...]